Ramroop knocks SN report on drugs
-says New GPC not fly-by-night company
New GPC’s Chief Executive Officer (CEO) Dr Ranjisinghi Ramroop has attacked a report in yesterday’s Stabroek News headlined `New GPC mum on quotation for malaria drugs supply’ charging that the article was malicious and aimed at destabilizing his company.
In an invited comment last evening Stabroek News Editor-in-Chief Anand Persaud said that Ramroop’s allegation was ludicrous and that SN would continue to press NGPC for answers on all matters that required clarification particularly in the arena of drug procurement.
A release from NGPC noted that the article adverted to a difference of over $228M between the two bidders for the supply of anti-malarial drugs: New GPC Inc and the International Pharmaceutical Agency (IPA). New GPC’s bid was …..To continue reading, login or subscribe now.